Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Quantum BioPharma Ltd
C.QNTM
Alternate Symbol(s):
QNTM
Healthcare
FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is...
focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:QNTM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(14)
•••
breakout
X
View Profile
View Bullboard History
Comment by
breakout
on Jul 10, 2023 4:51pm
RE:Don’t listen to milman he statement is false
I hope you get your first win and they throw the book at the short sellers. A short seller is in the same category as a thief. Do you know any thiefs Rosenberg?
(137)
•••
DavidRosenberg
X
View Profile
View Bullboard History
Post by
DavidRosenberg
on Jul 10, 2023 4:30pm
Don’t listen to milman he statement is false
FSD did market intelligence to investigate naked shorts milman https://finance.yahoo.com/news/fsd-pharma-symbol-huge-renews-123000628.html That's the one they hired , that's not a law
...more
(3)
•••
Mil_Man54
X
View Profile
View Bullboard History
Comment by
Mil_Man54
on Jul 10, 2023 3:51pm
RE:FSD going after naked shorts
They already retained a firm months ago to investgate naked shorting...remembe that Rosenberg...you pumped that multiple times a day....so what happened...why a second firm....I'm guessing the
...more
(137)
•••
DavidRosenberg
X
View Profile
View Bullboard History
Post by
DavidRosenberg
on Jul 10, 2023 7:47am
FSD going after naked shorts
Good luck everyone
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 10, 2023 7:31am
New Press Release - FSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders, today announces that the...
read article.
(14)
•••
breakout
X
View Profile
View Bullboard History
Comment by
breakout
on Jul 09, 2023 10:34pm
RE:FSD Pharma Lucid MS update
I was being sarcastic in a past post about Rosenberg being right 90% of the time. I really am pulling for him to get his first win though. Hey Rosenberg are you being sarcastic when you defend FSD or
...more
(137)
•••
DavidRosenberg
X
View Profile
View Bullboard History
Post by
DavidRosenberg
on Jul 09, 2023 1:27pm
FSD Pharma Lucid MS update
Check that link for updates on lucid ms ClinicalTrials.gov ID: NCT05821387 https://clinicaltrials.gov/study/NCT05821387?term=Lucid-21-302&rank=1
(14)
•••
breakout
X
View Profile
View Bullboard History
Comment by
breakout
on Jul 05, 2023 4:54pm
RE:Re: Hey Rosenberg
Rosenberg is always comparing things to Trump. How does the FSD management compare to Trump Rosenberg.
(23)
•••
JAKPUG4LIFE
X
View Profile
View Bullboard History
Post by
JAKPUG4LIFE
on Jul 05, 2023 1:31pm
Re: Hey Rosenberg
Like many of Rosenberg's predictions, pumps, and misleading statements since 2017. The close relationship with the leadership group is telling. I like the interm ceo on finding a solid
...more
(14)
•••
breakout
X
View Profile
View Bullboard History
Post by
breakout
on Jul 04, 2023 10:12pm
Hey Rosenberg
Hey Mr. ROSENBERG. May I ask how FSD PHARMA was able to afford the trials before the break through beverage was invented and now they are suppose to make tons of money and cant afford the trials
...more
(14)
•••
breakout
X
View Profile
View Bullboard History
Post by
breakout
on Jul 04, 2023 5:28pm
Name change no more psycheldelics?
FSD is going after the stockbuyers who are known as the good people. Hospitols churchs AA . They took the $5 that us trash drug addict pot entusiusts who went to visit pot growing facilities and such
...more
(83)
•••
Bigmac4000
X
View Profile
View Bullboard History
Post by
Bigmac4000
on Jul 04, 2023 3:54pm
Hey David spin this one like a DJ lol
"on hold and/or terminating any further clinical development of its proprietary ultra-micronized PEA formulation for the treatment of inflammatory diseases and Lucid-Psych for mental health
...more
(23)
•••
JAKPUG4LIFE
X
View Profile
View Bullboard History
Post by
JAKPUG4LIFE
on Jul 04, 2023 10:13am
News Release
LoL, but did they get more than 1 person to sign up for the trial this tme.. Musical Chairs at the helm of the ceo position. Saeed your up. Maybe they should look at their salaries and bonuses
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 04, 2023 10:00am
New Press Release - FSD Pharma Appoints Zeeshan Saeed as Chief Executive Officer, Anthony Durkacz to Serve as Executive Co-Chairman of the Board of Directors
Appointment culminates multi-year succession plan as FSD focuses on commercialization of its UNBUZZD™ alcohol misuse product and Lucid-MS for neurodegenerative disorders FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated...
read article.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed